| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/22/2001 | EP1124843A1 Low allergenic protein variants |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124603A1 Vaporizing device for administering sterile medication |
| 08/22/2001 | EP1124593A1 Method for preparing bone material |
| 08/22/2001 | EP1124583A1 Adeno-associated vectors for expression of factor viii by target cells |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124573A1 Methods for treating sepsis |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124571A1 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124557A2 Pharmaceutical composition |
| 08/22/2001 | EP1124542A1 Capsules with porous mineral cortex |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP1124427A1 Enzyme-based fungicide composition |
| 08/22/2001 | EP1124418A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP1085811A4 Broad specificity dna damage endonuclease |
| 08/22/2001 | EP0862418B1 Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 08/22/2001 | EP0831787B1 Composition for sustained release of human growth hormone |
| 08/22/2001 | EP0825871B1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | EP0696208B1 Oral drug delivery compositions |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | CN1309712A Method of making proteins in transformed yeast cells |
| 08/22/2001 | CN1309709A Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309705A IL-2 selective agonists and antagonists |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309662A Chemotaxis-inhibiting protein of i(staphylococcus) (CHIPS) and its use |
| 08/22/2001 | CN1309568A Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 08/22/2001 | CN1309567A FSH and FSH variant formulations, products and methods |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/22/2001 | CN1309562A Topical compositions comprising opioid analgesic and NMDA antagonist |
| 08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
| 08/22/2001 | CN1309555A Incorporation of active substances in carrier matrixes |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/22/2001 | CN1308965A Application for protease in preparing anastaltic |
| 08/22/2001 | CN1308937A Method for preparing microcapsule |
| 08/22/2001 | CN1069827C Polypeptide protein micro-beads medicine prepn. method |
| 08/21/2001 | US6278038 Mammalian melanocortin receptors and uses |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277991 For treatment of migraine, non-insulin dependent diabetes mellitus, sepsis, inflammation, incontinence, vasomotor disturbances such as hot flushes or hot flashes |
| 08/21/2001 | US6277981 Method for design and selection of efficacious antisense oligonucleotides |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277976 Or-1, an orphan receptor belonging to the nuclear receptor family |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277973 Dna which codes for epitopes of protein of defined amino acid sequence; antigens for vaccines and treatment of infections in animals; primers and probes for detection and diagnosis |
| 08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
| 08/21/2001 | US6277969 Nucleotide sequence of antibody which binds tumor necrosis factor; diagnosis; immunoassays; immunotherapy; angiogenesis inhibitors; anticarcinogenic/antiinflammatory agents |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
| 08/21/2001 | US6277961 Produced by treating starting solution at least twice with absorbant, removing absorbant, and recovering supernatant containing fibrinogen; storage stable at 4-25 degrees celsius for four weeks |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277955 Materials and method for the detection and treatment of Wegener's granulomatosis |
| 08/21/2001 | US6277874 Methods for the treatment of apolipoprotein E related diseases |
| 08/21/2001 | US6277863 Anticoagulant with reduced side effects |
| 08/21/2001 | US6277832 Anticarcinogenic agents |
| 08/21/2001 | US6277829 Dissolving azithromycin in solution of polybasic phosphate and citric acid; treatment of conjunctivitis, keratitis and blepharitis |
| 08/21/2001 | US6277828 Aqueous isotonic solutions containing human serum albumin, sodium chloride and citric acid, suitable for lyophilization, useful for the treatment of alzheimer's disease |
| 08/21/2001 | US6277826 Consisting of d-leucine, d-phenylalanine and d-valine; peptide is modified at the amino-terminus, the carboxy-terminus, or both with an amide or a hydroxy group |
| 08/21/2001 | US6277825 Having 10-30 amino acids, including at least two /gamma/-carboxyglutamic acid residues, for the treatment of pain |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277822 Family of peptides known as xenoxins |
| 08/21/2001 | US6277821 For treating gramnegative and mycobacterium infections; endotoxin and heparin neutralization |
| 08/21/2001 | US6277820 Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells |
| 08/21/2001 | US6277819 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 08/21/2001 | US6277818 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 08/21/2001 | US6277817 Human lactoferrin |
| 08/21/2001 | US6277813 Colostrum derived growth factor |
| 08/21/2001 | US6277812 Methods for inhibiting TGF-β activity |
| 08/21/2001 | US6277640 Antisense modulation of Her-3 expression |
| 08/21/2001 | US6277638 Producing nucleic acid fragments or polynucleotides conferring desired phenotype which encodes mutant proteins via repeated cycles of in vitro or in vivo recombination (mutagenesis, shuffling, and selection) |
| 08/21/2001 | US6277636 Antisense inhibition of MADH6 expression |
| 08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277619 Enzymatic polypeptide associated with generating glucose; for the diagnosis, treatment, and prevention of disorders of metabolism and cancer |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277603 Peptide nucleic acid (pna); the dna portion is composed of subunits of at least one 2'-deoxynucleotides; increased nuclease resistance; activate rnase h enzyme, use for in vitro modification of rna |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277597 Nucleotide sequences coding microbiocides; for the prevention of bacterial infection |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277593 Generating preferential polypeptide; culture transformed cells, express preferential polypeptide, recover preferential polypeptide |
| 08/21/2001 | US6277592 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 08/21/2001 | US6277591 Isolating nucleotide sequences coding g-protein coupled receptor; hybridize nucleotide sequences of sample and probe, isolate hybridization product, incubate with oligonucleotide probe and recover sequence coding transmembrane protein |
| 08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277575 Process aimed at evidencing the state of a malignant cell |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277565 OCT-3 gene encoding transporter-like molecules |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | US6277558 α-3 chain type IV collagen polynucleotides |